We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs, Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Daily Bulletin
    • Drug Industry Daily
  • Device News
    • Trending
    • Commercial Operations
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Daily Bulletin
    • FDAnews Device Daily Bulletin Premium
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • eCFR and Guidances
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Regulatory Affairs

Search the Store

Shop By Category

Drug Products

Drug Books

Device Products

Device Books

Clinical Products

Shop By Media

Books

Webinar Recordings

Featured Product In Regulatory Affairs

FDA’s Alternative Inspection Tools

FDA’s Alternative Inspection Tools: Expert Answers to Drug and Biologics Manufacturers’ Questions

$397.00
If you want to pass your next inspection, FDA’s Alternative Inspection Tools: Expert Answers to Drug and Biologics Manufacturers’ Questions is a must. Read More

Regulatory Affairs

Canada: New Premarket Requirements Aimed at Reducing Medication Errors

$40.00
Learn More

Industry: Plan to Expand Off-Label Uses in France Undermines EU Regulation

$40.00
Learn More

Irish Authority Deems 12 Active Substances Safe for OTC Use

$40.00
Learn More

Ombudsman Clears EMA in Rejection of Over-the-Counter Migraine Drug

$40.00
Learn More

Adoption of GPvP Guidelines Puts Australia in Line with EU Practice

$40.00
Learn More

EMA Manual Explains Ins and Outs of New Pharmacovigilance System

$40.00
Learn More

Japan’s PMDA Clarifies Requirements for Companion Diagnostic PMAs

$40.00
Learn More

FDA 4-Year Plan to Spur Increase in Global Regulatory Partnerships

$40.00
Learn More

Guidance: CDx Sponsors Should Meet Early With FDA on Submission Type

$25.00
Learn More

Japan Clarifies Requirements for Companion Diagnostics

$25.00
Learn More

Smart Labeling Self-Audits: Prescriptions for Global Regulatory Compliance

$397.00
Learn More

Cut Drug Approval Time with a 505(b)(2)

$397.00
Learn More
Previous 1 2 … 43 44 45 46 47 48 49 50 51 Next
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing